| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | calcium channel complex | 3.96e-04 | 73 | 41 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | MFSD2A ATP6AP1 GRIN3A ARL6IP1 ATP2A1 EBPL DNAJC25 PIEZO1 RYR1 | 7.45e-04 | 1293 | 41 | 9 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | MFSD2A ATP6AP1 GRIN3A ARL6IP1 ATP2A1 EBPL DNAJC25 PIEZO1 RYR1 | 7.71e-04 | 1299 | 41 | 9 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | MFSD2A ATP6AP1 GRIN3A ARL6IP1 ATP2A1 EBPL DNAJC25 PIEZO1 RYR1 | 8.98e-04 | 1327 | 41 | 9 | GO:0042175 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.43e-03 | 523 | 41 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 3.52e-03 | 45 | 41 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | transporter complex | 4.25e-03 | 550 | 41 | 5 | GO:1990351 | |
| Domain | LRRC37_N | 3.36e-08 | 4 | 39 | 3 | IPR032754 | |
| Domain | LRRC37AB_C | 3.36e-08 | 4 | 39 | 3 | PF14914 | |
| Domain | LRRC37AB_C | 3.36e-08 | 4 | 39 | 3 | IPR029423 | |
| Domain | LRRC37 | 3.36e-08 | 4 | 39 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 3.36e-08 | 4 | 39 | 3 | IPR015753 | |
| Domain | LRR_8 | 4.35e-04 | 171 | 39 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.95e-04 | 177 | 39 | 4 | IPR003591 | |
| Domain | LRR_TYP | 4.95e-04 | 177 | 39 | 4 | SM00369 | |
| Domain | LRR | 7.97e-04 | 201 | 39 | 4 | PS51450 | |
| Domain | LRR_1 | 1.10e-03 | 219 | 39 | 4 | PF00560 | |
| Domain | Leu-rich_rpt | 2.39e-03 | 271 | 39 | 4 | IPR001611 | |
| Domain | - | 4.39e-03 | 321 | 39 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 4.73e-03 | 328 | 39 | 4 | IPR032675 | |
| Domain | Ig_I-set | 7.24e-03 | 190 | 39 | 3 | IPR013098 | |
| Domain | I-set | 7.24e-03 | 190 | 39 | 3 | PF07679 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 22419166 | ||
| Pubmed | 1.68e-07 | 10 | 40 | 3 | 23064749 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15972723 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 23888875 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 9384575 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 18488020 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 10444070 | ||
| Pubmed | Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation. | 2.70e-05 | 7 | 40 | 2 | 29130937 | |
| Pubmed | Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. | 2.70e-05 | 7 | 40 | 2 | 7569905 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.60e-05 | 8 | 40 | 2 | 19033399 | |
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 4.62e-05 | 9 | 40 | 2 | 25640239 | |
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 18434328 | ||
| Pubmed | Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease. | 7.05e-05 | 11 | 40 | 2 | 31199454 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 32994313 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 22411552 | ||
| Pubmed | Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. | 1.95e-04 | 18 | 40 | 2 | 17425782 | |
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 35081489 | ||
| Pubmed | 5.87e-04 | 31 | 40 | 2 | 25645918 | ||
| Pubmed | 6.78e-04 | 149 | 40 | 3 | 22664934 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 8.83e-04 | 38 | 40 | 2 | 30786075 | |
| Pubmed | 1.03e-03 | 41 | 40 | 2 | 16740002 | ||
| Cytoband | 17q21.31 | 5.57e-05 | 82 | 41 | 3 | 17q21.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 8.33e-04 | 473 | 41 | 4 | chr17q21 | |
| Cytoband | 19q13.1 | 1.12e-03 | 55 | 41 | 2 | 19q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.04e-03 | 1192 | 41 | 5 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 6.72e-03 | 137 | 41 | 2 | chr9q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 6.81e-03 | 138 | 41 | 2 | chr9q33 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 3.32e-05 | 407 | 40 | 6 | M19541 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 4.33e-05 | 128 | 40 | 4 | M1966 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP | 4.33e-05 | 257 | 40 | 5 | M41025 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 6.14e-05 | 140 | 40 | 4 | M617 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 6.48e-05 | 142 | 40 | 4 | MM840 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 7.22e-05 | 146 | 40 | 4 | MM964 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 8.12e-05 | 9 | 40 | 2 | MM888 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 8.12e-05 | 9 | 40 | 2 | M2187 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 8.43e-05 | 704 | 40 | 7 | M45672 | |
| Coexpression | SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN | 1.06e-04 | 60 | 40 | 3 | M17268 | |
| Coexpression | TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL | 2.15e-04 | 572 | 40 | 6 | M41698 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 2.24e-04 | 196 | 40 | 4 | M6074 | |
| Coexpression | GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP | 2.29e-04 | 197 | 40 | 4 | M9797 | |
| Coexpression | GSE27786_LSK_VS_NKTCELL_DN | 2.33e-04 | 198 | 40 | 4 | M4756 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 2.38e-04 | 199 | 40 | 4 | M6099 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN | 2.42e-04 | 200 | 40 | 4 | M4616 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN | 2.42e-04 | 200 | 40 | 4 | M4632 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKTCELL_DN | 2.42e-04 | 200 | 40 | 4 | M4840 | |
| Coexpression | GSE3982_CTRL_VS_LPS_48H_DC_DN | 2.42e-04 | 200 | 40 | 4 | M5377 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 2.42e-04 | 200 | 40 | 4 | M6514 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN | 2.42e-04 | 200 | 40 | 4 | M3127 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | TMEM176A IL13RA1 REN ANGPTL2 TVP23A FCGRT AXL LGALS3BP SP140 | 2.77e-05 | 872 | 40 | 9 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K4 | 5.01e-05 | 215 | 40 | 5 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 6.55e-05 | 974 | 40 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K3 | 8.43e-05 | 240 | 40 | 5 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.96e-04 | 878 | 40 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | 1.96e-04 | 878 | 40 | 8 | gudmap_kidney_adult_RenCorpuscGlomer_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 3.03e-04 | 172 | 40 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 3.38e-04 | 72 | 40 | 3 | GSM605859_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K0 | 3.75e-04 | 182 | 40 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K0 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 3.90e-04 | 972 | 40 | 8 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.95e-04 | 734 | 40 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| ToppCell | primary_visual_cortex-Non-neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.79e-07 | 176 | 41 | 5 | 2c92f3f55d668cfe80051b5128160a6dc3aec4e8 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 6.12e-07 | 178 | 41 | 5 | 11a338032b59b936c5e65517c4160f7dd47a2cda | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 7.60e-07 | 186 | 41 | 5 | a0cc925af97e47efd0c9bc17c37963e8ad4e5b35 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-07 | 188 | 41 | 5 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-07 | 190 | 41 | 5 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | BAL-Control|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 195 | 41 | 5 | 9507ea0febcd8dd6a8a754c13a05f58494ffed7b | |
| ToppCell | Control|World / Disease group,lineage and cell class (2021.01.30) | 9.59e-07 | 195 | 41 | 5 | a5841b77182a78a71f968c4046ea586cbe78d727 | |
| ToppCell | BAL-Control|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.59e-07 | 195 | 41 | 5 | 8dd18c8e7b0f0baaf89fb5d8b0c864be292b4198 | |
| ToppCell | Healthy_Control|World / Condition, Lineage, Cell class and cell subclass | 9.59e-07 | 195 | 41 | 5 | c67bfa18f5d25e0f54ddf98d4e1c168296244b83 | |
| ToppCell | LAM-Myeloid-Macrophage|Myeloid / Condition, Lineage and Cell class | 1.01e-06 | 197 | 41 | 5 | 355fe286609df2ded973952f1856bbc5f437cfd0 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 1.06e-06 | 199 | 41 | 5 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | 980cb0390586d8312890e8d0f3cf58e3309d16c5 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | 3981873eceb69412ec02a35a734965472853c3fc | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | d7d971586c01152b3d21956fd98280588cb8f08b | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 1.09e-06 | 200 | 41 | 5 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | c439d4c62732ad660a60bc6577a4a6ca0f32a5b7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 9.04e-06 | 143 | 41 | 4 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | severe_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.29e-06 | 144 | 41 | 4 | c7f696e55e2d959c58ec32640c71ef86ee25203c | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 152 | 41 | 4 | d279592c501fca9cb474ad916fea32282e6969cb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 152 | 41 | 4 | 3b59143b2b4ee24eb6378f87ff568124193256e9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-05 | 153 | 41 | 4 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-05 | 153 | 41 | 4 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-05 | 153 | 41 | 4 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 157 | 41 | 4 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 157 | 41 | 4 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 160 | 41 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 164 | 41 | 4 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 2.09e-05 | 177 | 41 | 4 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 178 | 41 | 4 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 178 | 41 | 4 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.19e-05 | 179 | 41 | 4 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 2.24e-05 | 180 | 41 | 4 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-05 | 186 | 41 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-05 | 188 | 41 | 4 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.65e-05 | 188 | 41 | 4 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-05 | 188 | 41 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.71e-05 | 189 | 41 | 4 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-05 | 189 | 41 | 4 | c81b38cda4525254fe4fa137a4c9bc9abe0363bb | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.71e-05 | 189 | 41 | 4 | 807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-05 | 189 | 41 | 4 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-05 | 191 | 41 | 4 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-05 | 191 | 41 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 191 | 41 | 4 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.82e-05 | 191 | 41 | 4 | 92c5a26b90a55831039220341d863cf2940f3c9b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-RG|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.88e-05 | 192 | 41 | 4 | ee822325bb32ac7ad1eeccc23d966367e90a9edd | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.88e-05 | 192 | 41 | 4 | 6184163dbfca882824cb266bb9030d9f79e3acb0 | |
| ToppCell | Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.94e-05 | 193 | 41 | 4 | 18534bd60bdd1ce51f948380c78017679931b8b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-05 | 194 | 41 | 4 | f4286ae7bb8350c42d50727ee8688b80129714f6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-05 | 194 | 41 | 4 | 87461bd6d7f702c0a0f5e0c8ace3049125a51f9a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-05 | 194 | 41 | 4 | c578cf7c6b4d6f31f87dde8845de5b3891f16822 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 195 | 41 | 4 | 7dd0cb8f3753fe761fac200cbd161708b6528c51 | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 3.06e-05 | 195 | 41 | 4 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | LAM-Myeloid-Macrophage|LAM / Condition, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | 85abe51e47b567e6edcadfbe8cf02c2f2f0bb133 | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 3.06e-05 | 195 | 41 | 4 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-05 | 196 | 41 | 4 | 553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 196 | 41 | 4 | efdc95811e8b17243065ae82d748ea2c5775fdbc | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-05 | 196 | 41 | 4 | e1f763fa9c11bf5f4d80e79f70f9485724ac23fe | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-05 | 196 | 41 | 4 | d376168e15ec1cf618723259966c76be3698b9b0 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 3.12e-05 | 196 | 41 | 4 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.12e-05 | 196 | 41 | 4 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | MS-mDC2|MS / Condition, Cell_class and T cell subcluster | 3.12e-05 | 196 | 41 | 4 | 4707e4a911c6ea032f69aa1e431d5f4260bda011 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 196 | 41 | 4 | 3392efa5007736b1e87f34805c16e8baa792e596 | |
| ToppCell | MS-mDC2-|MS / Condition, Cell_class and T cell subcluster | 3.12e-05 | 196 | 41 | 4 | 064029b1376fa673f25f80596609be86ce0409a9 | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group, lineage and cell class | 3.12e-05 | 196 | 41 | 4 | 85d92bc226cc28384c30991cc4ebb02ec2e3ec99 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-05 | 196 | 41 | 4 | 4a9095ba3f6709f88f32bf09184553f4bd211f43 | |
| ToppCell | ILEUM-non-inflamed-(3)_Resident_macrophages|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.18e-05 | 197 | 41 | 4 | 3af24354b6a93c7d105b9fa6549cf215107b9203 | |
| ToppCell | 343B-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 41 | 4 | 1b6f7a62b7fcfd55c25c5840353eed7183050860 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.18e-05 | 197 | 41 | 4 | 8736f1d446db3eb28a99997a9a683ded8e18e4c6 | |
| ToppCell | VE-mDC2-|VE / Condition, Cell_class and T cell subcluster | 3.18e-05 | 197 | 41 | 4 | 6629588819ec31a7e4f33b94b8c035145a5f6c17 | |
| ToppCell | MNPs-Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 197 | 41 | 4 | 03d74643646dce5d3a278a1ee48c390d13a7889c | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.18e-05 | 197 | 41 | 4 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 3.18e-05 | 197 | 41 | 4 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.18e-05 | 197 | 41 | 4 | be9879e3352b8c17e91ab1e2d1fb4c30ef6d8ce8 | |
| ToppCell | mild_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 3.18e-05 | 197 | 41 | 4 | 63e7b040c64f1e28b8db79980c7b580caa7d1b95 | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 3.18e-05 | 197 | 41 | 4 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.18e-05 | 197 | 41 | 4 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | 2e622d75fb45cfa80f78e1880ad056a50709895a | |
| ToppCell | 367C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 41 | 4 | f5c21f0d363b5c298a2b82f6dff4f369397b5f25 | |
| ToppCell | VE-mDC2|VE / Condition, Cell_class and T cell subcluster | 3.18e-05 | 197 | 41 | 4 | e3172102ad17c92c3038cad37bf933eb04351048 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 3.24e-05 | 198 | 41 | 4 | 748db69d3c9774e44c0cc425d937d18b83af8312 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|World / Lineage, cell class and subclass | 3.24e-05 | 198 | 41 | 4 | 2ec42643200aa9feb33e2b87570f276fbad21cad | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 3.24e-05 | 198 | 41 | 4 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 198 | 41 | 4 | d4f74320ea6c1a7e568ee5bc48bb66cb45e1004d | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 3.24e-05 | 198 | 41 | 4 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.24e-05 | 198 | 41 | 4 | 382ad6ebc6e0274ace361de72c0a3df05c846456 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-05 | 198 | 41 | 4 | e1a0c809302a3b304775bd708201ad412a98d711 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | ff9c97c6f579a4e79859d420f224556fadc1f6ab | |
| ToppCell | myeloid-Dendritic_cell|World / Lineage, cell class and subclass | 3.24e-05 | 198 | 41 | 4 | 240fff8264caeb7d1efcbccb187fe93744559bbc | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 198 | 41 | 4 | 8a4b4bb6839b9ec52ff0b9c7b39cec8d9a9525bd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-05 | 199 | 41 | 4 | e225c1bfc55947c30e7948be851daea04975efa5 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.31e-05 | 199 | 41 | 4 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-AM-AM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.31e-05 | 199 | 41 | 4 | 255cf629351f35e516a5271d8758c29168ebd0cf | |
| ToppCell | BAL-Control-Myeloid-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.31e-05 | 199 | 41 | 4 | 0bf2ce7ebae9a77add8d72ec9ec0c6a022dfd092 | |
| ToppCell | BAL-Control-Myeloid-TRAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.31e-05 | 199 | 41 | 4 | a6a8d9e62d1c5948d1c5cd7643db6e482b31d165 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.31e-05 | 199 | 41 | 4 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-05 | 199 | 41 | 4 | ad2681b71fdf9644c9e639fca4beb9be37e27638 | |
| Drug | MDL-899 | 8.57e-06 | 3 | 39 | 2 | CID000071143 | |
| Drug | CHEMBL35507 | 1.48e-05 | 28 | 39 | 3 | CID013671153 | |
| Disease | aspartate aminotransferase measurement | 1.28e-03 | 904 | 40 | 6 | EFO_0004736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RWREPPPRLLWGCLM | 81 | Q6ZUL3 | |
| MGPISAPSCRWRIPW | 1 | P31997 | |
| VLRWERAWFPPAIMG | 36 | Q15041 | |
| MRPLCVTCWWLGLLA | 1 | Q9UKU9 | |
| SLLRMPPWVNIWLLG | 921 | O14983 | |
| MSLWPPFRCRWKLAP | 1 | A8MX76 | |
| MPLLWLRGFLLASCW | 1 | P08476 | |
| MRLLPEWFLLLFGPW | 1 | O95158 | |
| CVMSPLRFWGPWPLL | 11 | O60309 | |
| MLQRGLWPWRTRLLP | 1 | Q9NWR8 | |
| MWSRLVWLGLRAPLG | 1 | O43716 | |
| CVMSRLRFWGPWPLL | 11 | A6NM11 | |
| CVMSRLRFWGPWPLL | 11 | A6NMS7 | |
| CQLKWLPPWLIGRML | 446 | Q96JA1 | |
| MTPPRLFWVWLLVAG | 1 | Q08380 | |
| LMSGTRAWKWLRLPC | 396 | Q2TV78 | |
| WRRMRSGLPAPWISL | 321 | P55899 | |
| LCDLPRMPWAMIWDF | 16 | Q9H1B7 | |
| LLRTWPPDAMYRLWC | 161 | Q0VF49 | |
| GCWMTFLPEWLTRSP | 141 | Q9BY08 | |
| WGAARCWVLRRPMLA | 11 | P36776 | |
| MATARPPWMWVLCAL | 1 | Q9Y337 | |
| MEWPARLCGLWALLL | 1 | P78552 | |
| PPKCWTGRFLMNLWA | 736 | Q8TCU5 | |
| MCWLRAWGQILLPVF | 1 | P0DTF9 | |
| MWGRLLLWPLVLGFS | 1 | Q96RI0 | |
| PWTCLGRLMPWIIFS | 121 | Q8NA29 | |
| GRRWWMLLAPLLPAL | 16 | Q9H1X3 | |
| FPEARPWLMSARCWV | 496 | Q8NFT6 | |
| PWLMSARCWVRPFPF | 501 | Q8NFT6 | |
| EITLPMLCSYLPRWW | 3271 | P21817 | |
| MLCSYLPRWWERGPE | 3276 | P21817 | |
| LMRISPCRVWWRAPV | 126 | Q5VZR4 | |
| MPLPGGLWWLLCCRR | 1 | Q7Z736 | |
| SLTPLWLYCWRMFPT | 206 | Q96HP8 | |
| LELTGRWLLWPMLFP | 461 | Q9HCE1 | |
| RMPRWGLLLLLWGSC | 6 | P00797 | |
| WRWLAVLGCVPPSLM | 181 | Q9NY64 | |
| MCFLRRPGAPASWIW | 1 | Q6ZW05 | |
| RPGAPASWIWWRMLR | 6 | Q6ZW05 | |
| MLRPAGLWRLCRRPW | 1 | Q5TEU4 | |
| MAWRCPRMGRVPLAW | 1 | P30530 | |
| CAQALWRMPWLPVFL | 16 | Q15904 | |
| WRMPWLPVFLSLAAA | 21 | Q15904 | |
| RLSVRCGGWPLRWLM | 641 | Q13342 | |
| LWAMLSIPRPSKRFW | 1716 | Q92508 | |
| ARIFWLGLIICPMIW | 121 | A6NH52 |